185 related articles for article (PubMed ID: 16516705)
1. Successful lysis of coronary thrombi by long term warfarin treatment after a failed course of tirofiban infusion.
Boztosun B; Gunes Y; Kirma C; Barutcu I
Int J Cardiol; 2006 Mar; 108(1):114-6. PubMed ID: 16516705
[TBL] [Abstract][Full Text] [Related]
2. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
Rubboli A; Halperin JL
Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
[No Abstract] [Full Text] [Related]
3. Prevention of stroke in patients with atrial fibrillation.
Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
[No Abstract] [Full Text] [Related]
4. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
Roldán V; Marín F
Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
[No Abstract] [Full Text] [Related]
5. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting.
Karjalainen PP; Porela P; Ylitalo A; Vikman S; Nyman K; Vaittinen MA; Airaksinen TJ; Niemelä M; Vahlberg T; Airaksinen KE
Eur Heart J; 2007 Mar; 28(6):726-32. PubMed ID: 17267456
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding.
Khurram Z; Chou E; Minutello R; Bergman G; Parikh M; Naidu S; Wong SC; Hong MK
J Invasive Cardiol; 2006 Apr; 18(4):162-4. PubMed ID: 16729401
[TBL] [Abstract][Full Text] [Related]
8. Triple therapy: boon or bane for high-risk CV patients?
Phillippe HM; Baty SR; Griffith CB
J Fam Pract; 2011 Apr; 60(4):187-92. PubMed ID: 21472149
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous coronary intervention in neurosurgical patients.
Sullebarger JT; Wymer N; Holloway D
J Invasive Cardiol; 2008 Apr; 20(4):E133-5. PubMed ID: 18398246
[No Abstract] [Full Text] [Related]
10. [Two platelet inhibitors after acute coronary syndrome. Many colleagues are not aware of this].
MMW Fortschr Med; 2002 Mar; 144(13):50. PubMed ID: 12008695
[No Abstract] [Full Text] [Related]
11. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.
Helft G; Gilard M; Le Feuvre C; Zaman AG
Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):673-80. PubMed ID: 17122800
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban.
Thomas MD; Wood C; Lovett M; Dembo L; O'Driscoll G
J Heart Lung Transplant; 2008 Aug; 27(8):925-7. PubMed ID: 18656810
[TBL] [Abstract][Full Text] [Related]
13. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Jia de A; Cao Z; Nie B; Ge HL; Yang SW; Yan ZX
Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120
[TBL] [Abstract][Full Text] [Related]
14. Efficient tirofiban infusion resulting in resolution of intracoronary thrombus.
Acar G; Sökmen G; Nacar AB; Tuncer C
Turk Kardiyol Dern Ars; 2008 Apr; 36(3):197. PubMed ID: 18626216
[No Abstract] [Full Text] [Related]
15. Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes.
Testa L; Zoccai GB; Porto I; Trotta G; Agostoni P; Andreotti F; Crea F
Am J Cardiol; 2007 Jun; 99(12):1637-42. PubMed ID: 17560866
[TBL] [Abstract][Full Text] [Related]
16. Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?
Nguyen MC; Lim YL; Walton A; Lefkovits J; Agnelli G; Goodman SG; Budaj A; Gulba DC; Allegrone J; Brieger D;
Eur Heart J; 2007 Jul; 28(14):1717-22. PubMed ID: 17562671
[TBL] [Abstract][Full Text] [Related]
17. Short-term triple therapy with aspirin, warfarin, and a thienopyridine among patients undergoing percutaneous coronary intervention.
Porter A; Konstantino Y; Iakobishvili Z; Shachar L; Battler A; Hasdai D
Catheter Cardiovasc Interv; 2006 Jul; 68(1):56-61. PubMed ID: 16763985
[TBL] [Abstract][Full Text] [Related]
18. Overcoming "resistance" to aspirin and clopidogrel with tirofiban: fact or fiction?
Biondi-Zoccai G; Lotrionte M; Sheiban I
Thromb Haemost; 2008 Oct; 100(4):521-2. PubMed ID: 18841270
[No Abstract] [Full Text] [Related]
19. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
Hermosillo AJ; Spinler SA
Ann Pharmacother; 2008 Jun; 42(6):790-805. PubMed ID: 18477734
[TBL] [Abstract][Full Text] [Related]
20. Tirofiban optimizes platelet inhibition for immediate percutaneous coronary intervention in high-risk acute coronary syndromes.
Ivandic BT; Kurz K; Keck F; Staritz P; Lehrke S; Katus HA; Giannitsis E
Thromb Haemost; 2008 Oct; 100(4):648-54. PubMed ID: 18841288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
